The incidence falls 42 points since Friday although hospitalizations continue to rise

The 14-day incidence rate has experienced a further decline after the weekend and stands at 549.06 cases per 100,000 inhabitants. This is a drop of 42 points from the 591.14 recorded on Friday.

The incidence increases only in Castilla-La Mancha, in addition to Ceuta and Melilla. The communities that register the worst data at the moment are the Balearic Islands, with 750 cases, La Rioja (662), and Navarra (631).

This indicator also falls in the youngest groups, precisely those that dragged this fifth wave in July, although they still remain above the barrier of 1,000 cases. The group from 20 to 29 goes from 1,332 cases on Friday to 1,193 this Monday, while the group from 12 to 19 drops from 1,315 points on Friday to 1,203 after the weekend.

However, the upward trend in hospitalizations continues. There are currently 10,411 hospitalized for coronavirus, up from 10,015 on Friday, although the number is still below that registered the previous Monday. The number of patients in intensive care beds also increased, to 2,031. This means that ICU occupation with COVID patients already exceeds the 20% barrier (21.98).

How is the epidemic evolving now?

Evolution of the cases and deaths reported, those hospitalized and those admitted to the ICU each day and the variation in the last 7 days

Source: Ministry of Health

The autonomous regions with the worst data in this regard are Catalonia, which is close to 50%, Madrid, with 31% occupancy, and Castilla y León (20.63%).

Infections fell by 23% in the last week and this is beginning to be noticed slightly in hospital admissions, which fell by 2% in that period, but not yet in ICUs, where they have increased by 9% in the last seven days.

The Ministry of Health has reported in its daily report 39,638 cases registered during the weekend, which contrasts with the 55,939 recorded the previous Monday. In total, 4,627,770 people have been infected by coronavirus since the start of the pandemic.

The communities that report the highest increases after the weekend are Andalusia, with 8,491 positives reported since Friday; Catalonia, which totals 5,595; Madrid, with 4,931; and the Valencian Community, which scores 4,139.

Health authorities have also reported 119 deaths since Friday. This is a decrease compared to last Monday, which left 157 deaths. In total, 82,125 have died since the start of the health crisis. Despite the fact that infections and the incidence continue to fall, the number of daily deaths continues to rise, something that has also happened in previous waves: first there was a peak of infections, then hospitalizations and, finally, deaths.

70% of the population with at least one dose

Spain has vaccinated 33.4 million people with at least the first dose of the vaccine, more than 70% (70.4) of the population. Communities have exceeded that percentage this Friday after administering a total of 566,184 doses of any of the available vaccines against COVID-19 during the weekend.

In total, the communities have already given 59,108,679 doses since the start of the campaign, in December 2020, and 28.6 million people already have the full schedule, more than 60% (60.2) of the population. With this, the country is approaching the goal set by the Government of immunizing 70% of the population before the end of the summer.

Source: Ministry of Health (data updated to )

RNA vaccines driven by the pandemic open a “revolution” against diseases such as malaria or AIDS

With the global crisis due to the COVID-19 pandemic, a biotechnology race has been witnessed to obtain a vaccine against the coronavirus in the shortest possible time. This effort of world scientific knowledge has been the necessary impetus for the application of a type of technology that may mean the future for vaccines and treatments of different diseases: messenger RNA (mRNA).

Although it is too early to know exactly, vaccines based on this technology “are going to be a revolution. They have already done it with COVID-19, and the people who have developed this vaccination technology are clear candidates for the Nobel Prize,” he says. Raúl Rivas, professor of Microbiology and scientific communicator.


Source link